Acute Hypoxemic Failure

Acute hypoxemic failure represents a life-threatening condition where the lungs are unable to provide sufficient oxygen to meet the body’s metabolic demands. It often arises from severe pneumonia, acute respiratory distress syndrome, pulmonary embolism, or massive trauma that impairs gas exchange across the alveolar-capillary membrane. Patients typically present with profound shortness of breath, tachypnea, cyanosis, and altered mental status, requiring immediate recognition and intervention. Diagnosis of acute hypoxemic failure relies on arterial blood gas analysis, which reveals critically low partial pressure of oxygen, and supportive imaging to identify underlying causes. Management strategies focus on rapid stabilization of oxygenation and treatment of the precipitating disorder. Supplemental oxygen is the initial step, but many patients require advanced support such as high-flow nasal cannula, non-invasive ventilation, or invasive mechanical ventilation to maintain adequate gas exchange. In cases of refractory hypoxemia, extracorporeal membrane oxygenation (ECMO) may be considered as a rescue therapy. Equally important is the correction of underlying pathology, whether through antibiotics, anticoagulation, or targeted therapies. Acute hypoxemic failure also underscores the importance of careful fluid management, lung-protective ventilation strategies, and multidisciplinary critical care to minimize complications such as ventilator-associated lung injury. Long-term follow-up may be necessary, as survivors are at risk of persistent lung impairment and reduced functional capacity. Ongoing research is advancing predictive biomarkers, novel ventilation techniques, and pharmacologic interventions to improve survival and recovery in patients with acute hypoxemic failure.